SEC Form 4 · accession 0001615186-18-000008

ICU MEDICAL INC/DE · ICUI

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Thomas D McCall

Officer — Vice President and Gen'l Mgr.

Period of report

Aug 23, 2018

Accepted (ET)

Aug 27, 2018 · 3:22 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0000883984

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock	Aug 23, 2018	X	827	$58.79	A	3,018	D
Common Stock^F1	Aug 23, 2018	S	1,599	$300.34	D	1,419	D
Common Stock	Aug 23, 2018	X	563	$61.76	A	1,982	D
Common Stock	Aug 23, 2018	X	209	$60.40	A	2,191	D
Common Stock	Aug 24, 2018	X	7,392	$88.76	A	9,583	D
Common Stock	Aug 24, 2018	X	2,142	$58.79	A	11,725	D
Common Stock^F2	Aug 24, 2018	S	6,633	$302.70	D	5,092	D
Common Stock^F3	Aug 24, 2018	S	2,901	$303.45	D	2,191	D

Table II — derivative securities

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Non-Qualified Stock Option (right to buy)^F4	$58.79	Aug 23, 2018	X	827	D	—	Feb 24, 2024	Common Stock	827	2,142	D
Non-Qualified Stock Option (right to buy)^F4	$58.79	Aug 24, 2018	X	2,142	D	—	Feb 24, 2024	Common Stock	2,142	0	D
Non-Qualified Stock Option (right to buy)^F4	$60.40	Aug 23, 2018	X	209	D	—	Oct 11, 2022	Common Stock	209	0	D
Non-Qualified Stock Option (right to buy)^F4	$61.76	Aug 23, 2018	X	563	D	—	Feb 6, 2023	Common Stock	563	0	D
Non-Qualified Stock Option (right to buy)^F5	$88.76	Aug 24, 2018	X	7,392	D	—	Feb 11, 2025	Common Stock	7,392	0	D

Explanation of responses

F1The price recorded in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $300.00 to $301.00, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
F2The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $302.35 to $303.30, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
F3The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $303.38 to $303.65, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
F4Options vest and are exercisable as to 25% of the underlying grant one year after the date of grant and in equal monthly installments thereafter for three additional years.
F5Options exercisable one-third annually over the first three anniversaries of the grant date.